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Background: Squamous cell carcinoma (SCC) as the malignant component of carcinoma ex pleomorphic adenoma
(CXPA) occurring in upper lip is rare.
Case report: A 55-year-old male patient presented with an asymptomatic mass of the upper lip that had noticed
8 years previously. The mass was clinically suspected to be a benign salivary gland tumor based on palpation and
magnetic resonance imaging findings. A needle biopsy was then carried out, and the pathological diagnosis was
pleomorphic adenoma. The tumor was removed under general anesthesia. Histopathological examination revealed
well-demarcated tumor tissues showing typical histologic features of pleomorphic adenoma. However, SCC tissue
with several mitotic figures was found in the central area of the tumor tissue. The tumor was finally diagnosed as
CXPA. There was no evidence of recurrence or metastasis 6 years postoperatively.
Conclusion: This is the first report of CXPA of the upper lip with an unusual malignant component of SCC.
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Carcinoma ex pleomorphic adenoma (CXPA), described
as a rare malignant epithelial tumor arising from a pre-
existing pleomorphic adenoma (PA), accounts for approxi-
mately 12% of all salivary gland malignancies and 6.2% of
all PAs [1]. CXPA most frequently arises in the parotid
gland. However, it may also originate from the subman-
dibular glands and minor salivary glands, most commonly
those in the palate and rarely those in the upper lip [2].
The typical history is that of a chronic mass present
much longer than 3 years, with rapid growth over the pre-
vious few months. Histopathologically, the malignant
component is most frequently a poorly differentiated
adenocarcinoma or undifferentiated carcinoma, but un-
commonly is a squamous cell carcinoma (SCC) [1]. We
herein present an extremely rare case of CXPA of the
upper lip with an unusual malignant component of SCC.* Correspondence: skawano@dent.kyushu-u.ac.jp
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A 55-year-old male patient presented with an asymptom-
atic mass of the upper lip that he had noticed 8 years
previously. His past medical history included depression.
The patient’s systemic findings were a good constitution
and nourished condition. Intraoral examination revealed
a painless, apparently circumscribed, movable, elastic
hard, and little-finger-sized tumor mass in the upper lip
(Figure 1A). No sensory or motor paralysis was observed
in the maxillofacial region. No abnormal findings were ob-
served in the bilateral cervical lymph nodes. Gadolinium-
enhanced T1-weighted magnetic resonance imaging
showed that the tumor mass had clear boundaries and
low-signal intensity (Figure 1B). On T2-weighted images,
the mass showed slight high-signal intensity with internal
heterogeneity (Figure 1C). These findings suggested the
presence of a benign tumor in the upper lip. Needle biopsy
was thus carried out, and the pathological diagnosis
was PA (Figure 2A). The tumor was removed under gen-
eral anesthesia. Grossly, the cut surface of the excised
tumor was glistening, heterogeneous, and tan (Figure 2B).Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Intraoral findings and magnetic resonance images. (A) An elastic hard mass is located in the right upper lip. Magnetic resonance
images show an apparently circumscribed mass lesion in the right upper lip. (B) T1-weighted image. (C) T2-weighted image.
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features of PA; the tumor was well demarcated and
completely encapsulated (Figure 2C). However, a well-
differentiated SCC component was found in the central
region of the tumor. The tumor was finally diagnosed as
CXPA. There was no focal capsular invasion of malignant
cells or infiltration into the adjacent normal tissue. We
thus chose a wait-and-see approach without postoperative
treatment. There was no evidence of recurrence or metas-
tasis for 6 years after the operation.
Pathologic findings
The specimen obtained by needle biopsy showed a
proliferation of polygonal epithelial and myoepithelial
cells in myxomatous, fibrous, and hyaline backgrounds.
Typical bilayered ductal structures comprising these
cells were observed. These histological features are usu-
ally noted in PA (Figure 2A). Meanwhile, the sample
removed during the operation revealed that the well-
differentiated SCC component was located in the central
region of the tumor (Figure 2C). However, no extracapsular
invasion of malignant cells into the adjacent normal tissuewas found. The border between the PA and SCC was un-
clear and intermingled (Figure 2D,E). In the PA region, the
round and ovoid epithelial cells showed a compact cellular
arrangement in the form of a large sheet with myxoid and
fibrous stromata (Figure 2F). In the SCC region, cancer
cells with several mitotic figures showed invasive growth
and individual cell keratinization (Figure 2G).
Discussion
Malignant derivatives of PA of salivary gland origin are
rare and include three types. CXPA is the most common
malignant change, whereas carcinosarcoma and metasta-
sizing PA are less common. CXPA is further subclassified
into a noninvasive type, minimally invasive type (≤1.5 mm
penetration of the malignant component into the
extracapsular tissue), and invasive type (>1.5 mm invasion
from the tumor capsule into adjacent tissues) [3]. Nonin-
vasive CXPA is also referred to as carcinoma in situ arising
in PA. The prognoses of first two types are usually favor-
able, while the latter has a guarded prognosis. In the
present case, the CXPA was a noninvasive type because
the tumor was completely encapsulated and extracapsular
Figure 2 Resected specimens and histopathological findings (hematoxylin and eosin stain). (A) The specimen obtained by needle biopsy
shows typical histopathologic features of pleomorphic adenoma (PA). Bar = 100 μm. (B) The cut surface of the excised tumor is glistening,
heterogeneous, and tan. Bar = 10 mm. (C) The loupe image shows that the tumor is completely encapsulated. The malignant component is
located in the central area of the tumor. The arrowhead shows the labial mucosa. The dotted lines indicate the squamous cell carcinoma (SCC)
component. Bar = 10 mm. (D) The unclear borderline between the PA and SCC components at low magnification. Arrowheads and asterisks
show ductal structures and well-differentiated squamous cell component, respectively. Bar = 100 μm. (E) High magnification of Figure 2D.
Bar = 50 μm. (F) The PA region. Bar = 100 μm. (G) The SCC region. Arrows show mitotic figure of cancer cells. Bar = 50 μm.
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pathologically seen. The malignant component of CXPA is
most frequently a poorly differentiated adenocarcinoma orundifferentiated carcinoma [3]. Seifert and colleagues [4]
reported 38 cases of CXPA, among which SCC accounted
for 10% of the histologic variety of malignant components.
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colleagues [5] and 37 cases of CXPA reported by Tortoledo
and colleagues [6], no malignant components were classi-
fied as SCC. SCC as the malignant component of CXPA
thus seems to be rare; only a few such case reports are
present in the English language literature [7-10]. In the
present case, the SCC nests showed no continuity with the
labial mucosa, and extracapsular invasion was not ob-
served. Taken together, these findings suggest that the SCC
originated from the epithelial component of the PA.
CXPA in the minor salivary glands commonly occurs
in the palatal region, although in rare cases it can be
found in the lip [2]. Therefore, from the point of view of
the tumor origin and pathological features, this case
seems to be extremely rare. It is the first report of CXPA
of the upper lip with an unusual malignant component
of SCC. Lewis and colleagues [5] reported that all pa-
tients with intracapsular carcinoma were alive and well
without evidence of disease progression. However, CXPA
generally displays aggressive and destructive behavior
and has high recurrence and metastatic rates. Careful
follow-up is thus necessary, although there has been no
evidence of recurrence or metastasis in the present case.Conclusion
This is the first report of CXPA of the upper lip with an
unusual malignant component of SCC. The SCC origi-
nated from the epithelial component of the PA.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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